Skip to main content
OpenTrials

Clinical trial condition

Uterine Cancer

Explore clinical trials studying Uterine Cancer. Study availability and eligibility vary by location and protocol.

92 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Uterine Cancer trial results

Completed

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT05864144

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +101 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Medical Aurora, Colorado, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Henry Ford Cancer Detroit, Michigan, United States
View Trial Details
Completed

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

NCT05708950

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +76 more
Locations
  • UCLA Health (Santa Monica Cancer Care) Santa Monica, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Sarasota, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Completed

A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma

NCT03395080

Conditions
Adnexal Diseases, Carcinosarcoma, Endocrine Gland Neoplasms, +23 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • HonorHealth Scottsdale, Arizona, United States
  • Florida Cancer Specialists & Research Institute West Palm Beach, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 17 locations
View Trial Details
Completed

PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine

NCT05697198

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +68 more
Locations
  • Clinical Site Fort Payne, Alabama, United States
  • Clinical Site Orange City, Florida, United States
  • Clinical Site Stuart, Florida, United States
  • Clinical Site Dublin, Georgia, United States
View Trial Details

Related conditions